GSK3 beta activity alleviates epileptogenesis and limits GluA1 phosphorylation

Background: Glycogen synthase kinase-3 beta (GSK3 beta) is a key regulator of cellular homeostasis. In neurons, GSK3 beta contributes to the control of neuronal transmission and plasticity, but its role in epilepsy remains to be defined. Methods: Biochemical and electrophysiological methods were used to assess the role of GSK3 beta in regulating neuronal transmission and epileptogenesis. GSK3 beta activity was increased genetically in GSK3 beta[S9A] mice. Its effects on neuronal transmission and epileptogenesis induced by kainic acid were assessed by field potential recordings in mice brain slices and video electroencephalography in vivo. The ion channel expression was measured in brain samples from mice and followed by analysis in samples from patients with temporal lobe epilepsy or focal cortical dysplasia in correlation to GSK3 beta phosphorylation. Findings: Higher GSK3 beta activity decreased the progression of kainic acid induced epileptogenesis. At the biochemical level, higher GSK3 beta activity increased the expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel 4 under basal conditions and in the epileptic mouse brain and decreased phosphorylation of the glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluA1 at Serine 831 under basal conditions. Moreover, we found a significant correlation between higher inhibitory-GSK3 beta phosphorylation at Serine 9 and higher activating GluA1 phosphorylation at Serine 845 in brain samples from epileptic patients. Interpretation: Our data imply GSK3 beta activity in the protection of neuronal networks from hyper-activation in response to epileptogenic stimuli and indicate that the anti-epileptogenic function of GSK3 beta involves modulation of HCN4 level and the synaptic AMPA receptors pool. (c) 2018 The Authors. Published by Elsevier B.V.